Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) — Cash Flow Reinvestment Rate
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) has a Cash Flow Reinvestment Rate of 0.20x as of June 2025, reinvesting CN¥7.27 Million (capex CN¥7.27 Million ) from operating cash flow of CN¥36.25 Million. Check Tonghua Golden-Horse Pharmaceutical Indu (000766) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Cash Flow Reinvestment Rate (2000–2025)
Historical reinvestment intensity for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd across 21 annual periods. Explore cash flow to debt ratio of Tonghua Golden-Horse Pharmaceutical Indu to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (2000–2025)
Year-by-year capital reinvestment analysis for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd. For live market cap and broader valuation context, see Tonghua Golden-Horse Pharmaceutical Indu market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.61x | CN¥64.07 Million | CN¥105.05 Million | CN¥64.07 Million | ▲ +1.0% |
| 2024 | 0.60x | CN¥98.30 Million | CN¥162.75 Million | CN¥49.17 Million | ▼ -31.7% |
| 2023 | 0.88x | CN¥99.80 Million | CN¥112.78 Million | CN¥26.67 Million | ▲ +611.4% |
| 2022 | 0.12x | CN¥24.65 Million | CN¥198.16 Million | CN¥23.74 Million | ▼ -32.5% |
| 2021 | 0.18x | CN¥25.49 Million | CN¥138.33 Million | CN¥25.48 Million | ▼ -97.1% |
| 2020 | 6.40x | CN¥516.17 Million | CN¥80.71 Million | CN¥19.16 Million | ▼ -47.3% |
| 2019 | 12.14x | CN¥908.82 Million | CN¥74.86 Million | CN¥60.98 Million | ▲ +772.1% |
| 2018 | 1.39x | CN¥237.66 Million | CN¥170.72 Million | CN¥74.40 Million | ▼ -81.1% |
| 2017 | 7.37x | CN¥194.94 Million | CN¥26.43 Million | CN¥118.10 Million | ▼ -58.5% |
| 2016 | 17.77x | CN¥1.61 Billion | CN¥90.63 Million | CN¥169.40 Million | ▲ +232.5% |
| 2014 | 5.34x | CN¥183.39 Million | CN¥34.32 Million | CN¥183.39 Million | ▲ +249.0% |
| 2013 | 1.53x | CN¥157.66 Million | CN¥102.96 Million | CN¥157.66 Million | ▲ +336.0% |
| 2010 | 0.35x | CN¥10.20 Million | CN¥29.05 Million | CN¥10.20 Million | ▲ +113.7% |
| 2009 | 0.16x | CN¥13.14 Million | CN¥79.94 Million | CN¥13.14 Million | ▼ -77.5% |
| 2008 | 0.73x | CN¥7.48 Million | CN¥10.26 Million | CN¥7.48 Million | ▲ +41.6% |
| 2007 | 0.51x | CN¥5.12 Million | CN¥9.95 Million | CN¥5.12 Million | ▲ +4.8% |
| 2005 | 0.49x | CN¥17.55 Million | CN¥35.74 Million | CN¥17.55 Million | ▲ +115.1% |
| 2004 | 0.23x | CN¥4.37 Million | CN¥19.12 Million | CN¥4.37 Million | ▼ -74.6% |
| 2003 | 0.90x | CN¥82.57 Million | CN¥91.99 Million | CN¥82.57 Million | ▲ +277.1% |
| 2002 | 0.24x | CN¥17.31 Million | CN¥72.70 Million | CN¥17.31 Million | ▼ -87.0% |
| 2000 | 1.84x | CN¥360.49 Million | CN¥196.15 Million | CN¥360.49 Million | — |